HSS Journal ®

, Volume 7, Issue 2, pp 194–205 | Cite as

Surgical Arthritis Service Weekly Rounds: Ankylosing Spondylitis

  • Susan Goodman
  • Alana Levine
  • Seth Jerabek
  • Mark Figgie
Rheumatology Corner/CME Article

Statement of Need

There is a lack of literature discussing the management of multisystem involvement in patients with inflammatory arthritis, such as ankylosing spondylitis. As a result, patients with ankylosing spondylitis may be overlooked in attention to their joint disease; therefore cardiac or pulmonary disease may not be assessed appropriately in these patients. The overall collaborative management of this complex disease, with teamwork involving orthopedists and rheumatologists, should facilitate rehabilitation and mobility which will improve patient outcomes.

Target Audience

This activity is targeted at primary care physicians, specialty physicians, orthopedic surgeons, general medicine, residents, and fellows.


Hospital for Special Surgery professional education activities are intended to improve knowledge, competence and performance of our learners and to lead to better patient care. At the conclusion of the activity, the participant should be able to:
  • Describe the...


Ankylose Spondylitis Heterotopic Ossification Left Knee Knee Society Score Pyoderma Gangrenosum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ahmad N, Channa AB, Mansoor A, Hussain A. Management of difficult intubation in a patient with ankylosing spondylitis—a case report. Middle East J Anesthesiol. 2005;2:379–384.Google Scholar
  2. 2.
    Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: A cross-sectional analysis. Osteoporos Int. 2010.Google Scholar
  3. 3.
    Bhan S, Eachempati KK, Malhotra R. Primary cementless total hip arthroplasty for bony ankylosis in patients with ankylosing spondylitis. J Arthroplasty. 2008;6:859–866.CrossRefGoogle Scholar
  4. 4.
    Borman P, Bodur H, Bingol N, Bingol S, Bostan EE. Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: Relationship to disease activity. J Clin Rheumatol. 2001;5:315–321.CrossRefGoogle Scholar
  5. 5.
    Chen HA, Chen CH, Liao HT, Lin YJ, Chen PC, Chen WS, Chou CT. Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis. Semin Arthritis Rheum. 2010.Google Scholar
  6. 6.
    Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: Risk factors, prevention, and treatment. J Am Acad Orthop Surg. 2002;6:409–416.CrossRefGoogle Scholar
  7. 7.
    Kaarela K, Jantti JK, Kotaniemi KM. Similarity between chronic reactive arthritis and ankylosing spondylitis.A 32–35-year follow-up study. Clin Exp Rheumatol. 2009;2:325–328.Google Scholar
  8. 8.
    Kanathur N, Lee-Chiong T. Pulmonary manifestations of ankylosing spondylitis. Clin Chest Med. 2010;3:547–554.CrossRefGoogle Scholar
  9. 9.
    Kubiak EN, Moskovich R, Errico TJ, Di Cesare PE. Orthopaedic management of ankylosing spondylitis. J Am Acad Orthop Surg. 2005;4:267–278.CrossRefGoogle Scholar
  10. 10.
    Kwon E, Fleisher LA, Eagle. Cardiac risk assessment in noncardiac surgery. in:Perioperative medicaine: Managing for outcome. In: ; 2008.Google Scholar
  11. 11.
    Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis. A systematic review and metaanalysis. Arthritis Care Res (Hoboken). 2010.Google Scholar
  12. 12.
    McCarey D, Sturrock RD. Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 2009;4 Suppl 55:S124–6.Google Scholar
  13. 13.
    Parvizi J, Duffy GP, Trousdale RT. Total knee arthroplasty in patients with ankylosing spondylitis. J Bone Joint Surg Am. 2001;9:1312–1316.CrossRefGoogle Scholar
  14. 14.
    Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE,Jr, Cross JT,Jr, Fitterman N, Sherif KD, Weiss KB, Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: A guideline from the american college of physicians. Ann Intern Med. 2006;8:575–580.CrossRefGoogle Scholar
  15. 15.
    Rudwaleit M. Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis. J Rheumatol. 2010;8:1553–1555.CrossRefGoogle Scholar
  16. 16.
    Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans B, Dougados M, Emery P, van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlam K, Sieper J. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;6:770–776.CrossRefGoogle Scholar
  17. 17.
    Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;6:777–783.CrossRefGoogle Scholar
  18. 18.
    Schett G, Rudwaleit M. Can we stop progression of ankylosing spondylitis?. Best Pract Res Clin Rheumatol. 2010;3:363–371.CrossRefGoogle Scholar
  19. 19.
    Smetana GW, Lawrence VA, Cornell JE, American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the american college of physicians. Ann Intern Med. 2006;8:581–595.CrossRefGoogle Scholar
  20. 20.
    Sochart DH, Porter ML. Long-term results of total hip replacement in young patients who had ankylosing spondylitis. Eighteen to thirty-year results with survivorship analysis. J Bone Joint Surg Am. 1997;8:1181–1189.CrossRefGoogle Scholar
  21. 21.
    Sweeney S, Gupta R, Taylor G, Calin A. Total hip arthroplasty in ankylosing spondylitis: Outcome in 340 patients. J Rheumatol. 2001;8:1862–1866.Google Scholar
  22. 22.
    Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC,Jr, Dijkmans B, Dougados M, Geher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Bohm H, van Royen BJ, Braun J, ‘ASsessment in AS’ international working group, European League Against Rheumatism. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006;4:442–452.CrossRefGoogle Scholar

Copyright information

© Hospital for Special Surgery 2011

Authors and Affiliations

  • Susan Goodman
    • 1
  • Alana Levine
    • 1
  • Seth Jerabek
    • 2
    • 3
  • Mark Figgie
    • 2
    • 3
  1. 1.The Division of RheumatologyHospital for Special SurgeryNew YorkUSA
  2. 2.The Department of Orthopedic SurgeryHospital for Special SurgeryNew YorkUSA
  3. 3.The Department of Orthopedic SurgeryWeill Cornell College of MedicineNew YorkUSA

Personalised recommendations